Clonidine and Ocrevus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clonidine (clonidine) and Ocrevus (ocrelizumab). Common drug interactions include mobility decreased among females and urinary tract infection among males.

The phase IV clinical study analyzes what interactions people have when they take Clonidine and Ocrevus. It is created by eHealthMe based on reports of 63 people who take the same drugs from the FDA, and is updated regularly.

What is Clonidine?

Clonidine has active ingredients of clonidine. It is often used in high blood pressure. eHealthMe is studying from 65,644 Clonidine users. Check the latest studies of Clonidine.

What is Ocrevus?

Ocrevus has active ingredients of ocrelizumab. eHealthMe is studying from 56,583 Ocrevus users. Check the latest studies of Ocrevus.



On Jul, 19, 2026

63 people who take Clonidine and Ocrevus together, and have interactions are studied.

Clonidine and Ocrevus drug interactions.

What are the common drug interactions of Clonidine and Ocrevus, by gender? *:

female:

  1. Mobility decreased (ability to move is reduced)
  2. Optic neuritis (optic nerve inflammation)
  3. Secretion discharge
  4. Dysuria (painful or difficult urination)
  5. Pneumonia
  6. Vertigo
  7. Acoustic neuroma (primary intracranial tumour)
  8. Arthropathy
  9. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
  10. Cervical spinal stenosis (narrowing of the spinal canal in the neck)

male:

  1. Urinary tract infection
  2. Fatigue (feeling of tiredness)
  3. Rash
  4. Skin burning sensation
  5. Swelling
  6. Syncope (loss of consciousness with an inability to maintain postural tone)
  7. Dry skin
  8. Folliculitis (infection of hair root)
  9. Infected skin ulcer
  10. Keratosis pilaris (a condition in which there are numerous rough follicular spots, which may be skin coloured, red or brown)

What are the common drug interactions of Clonidine and Ocrevus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  2. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
  3. Dyspnoea (difficult or laboured respiration)
  4. Fall
  5. Nausea (feeling of having an urge to vomit)
  6. Rash
  7. Vitamin d decreased
  8. Drug ineffective
  9. Folate deficiency (lack of folic acid)
  10. Oral herpes (viral infection of mouth)

30-39:

  1. Contusion (a type of hematoma of tissue in which capillaries)
  2. Gait disturbance
  3. Mobility decreased (ability to move is reduced)
  4. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  5. Skin burning sensation
  6. Swelling
  7. Syncope (loss of consciousness with an inability to maintain postural tone)
  8. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  9. Back pain
  10. Balance disorder

40-49:

  1. Fatigue (feeling of tiredness)
  2. Urinary tract infection
  3. Back pain
  4. Fall
  5. Limb discomfort (discomfort in leg)
  6. Mobility decreased (ability to move is reduced)
  7. Optic neuritis (optic nerve inflammation)
  8. Sinusitis (inflammation of sinus)
  9. Headache (pain in head)
  10. Asthenia (weakness)

50-59:

  1. Ear discomfort
  2. Encephalopathy (functioning of the brain is affected by some agent or condition)
  3. Gait disturbance
  4. Hypoaesthesia (reduced sense of touch or sensation)
  5. Menopause (end of monthly cycles in women)
  6. Muscular weakness (muscle weakness)
  7. Nasal septum deviation (deviated nasal septum)
  8. Nasopharyngitis (inflammation of the nasopharynx)
  9. Nausea (feeling of having an urge to vomit)
  10. Pain in extremity

60+:

  1. Dizziness
  2. Fatigue (feeling of tiredness)
  3. Dyspnoea (difficult or laboured respiration)
  4. Gait disturbance
  5. Nausea (feeling of having an urge to vomit)
  6. Visual impairment
  7. Hypoaesthesia (reduced sense of touch or sensation)
  8. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  9. Asthenia (weakness)
  10. Haemorrhage (bleeding)

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 30 people, 47.62%
  2. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 27 people, 42.86%
  3. Nausea (feeling of having an urge to vomit): 10 people, 15.87%
  4. Depression: 10 people, 15.87%
  5. Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 10 people, 15.87%
  6. Stress And Anxiety: 9 people, 14.29%
  7. Oral Herpes (viral infection of mouth): 6 people, 9.52%
  8. Asthma: 6 people, 9.52%
  9. Pain: 5 people, 7.94%
  10. Hypersensitivity: 5 people, 7.94%

* Approximation only. Some reports may have incomplete information.

Do you take Clonidine and Ocrevus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Clonidine and Ocrevus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Clonidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ocrevus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Clonidine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ocrevus and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on clonidine and ocrelizumab (the active ingredients of Clonidine and Ocrevus, respectively), and Clonidine and Ocrevus (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: